Skip to main content
OpenTrials
Completed

NCT Number: NCT00227877

Screening and Brief Advice to Reduce Teen Substance Use

The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).

We hypothesize that:

1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use; 2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use; 3. Among 12-18 year old well care patients who are at risk for riding with an impaired driver or driving while impaired, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing Riding/Driving risk behavior as measured by a standardized scale.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Related Disorders Alcohol-Related Disorders Alcoholism Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

12 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for the Evaluation, Prevention, and Research of Substance Abuse, Prague, Czechia

Loading trial locations.

About this study

We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.

We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

12-18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English

Exclusion criteria

Will not be available for 12 month follow-up period, Medically unstable at the time of the visit

Treatment and study plan

cSBA - New England, USA

Behavioral

Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.

Other names: SBIRT

cSBA - Prague, CZR

Behavioral

Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.

Other names: SBIRT

Primary outcomes

  1. Past-90-day Substance Use at 3 Months Among Baseline Substance Users - New England, USA

    Time frame: Past-90-days at 3 months post-baseline

    Among the 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment.

  2. Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users, New England, USA

    Time frame: Past-90-days at 3 months post-baseline

    Among the 12-18 year old primary care patients who did NOT report past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment.

  3. Past-12-month Substance Use at 12 Months Among Baseline Substance Users, New England, USA

    Time frame: Past-12-months at 12 months post-baseline

    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA

  4. Past-12-month Substance Use at 12 Months, Baseline Substance Non-Users, New England, USA

    Time frame: Past-12-months at 12 months post-baseline

    Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA

  5. Past-90-day Substance Use at 3 Months Among Baseline Substance Users - Prague, CZR

    Time frame: Past-90-days at 3 months post-baseline

    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic

  6. Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users - Prague, CZR

    Time frame: Past-90-days at 3 months post-baseline

    Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic

  7. Past-12-Month Substance Use at 12 Months Among Baseline Substance Users - Prague, CZR

    Time frame: Past-12-months at 12 months post-baseline

    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic

  8. Past-12-Month Substance Use at 12 Months Among Baseline Substance Non-Users - Prague, CZR

    Time frame: Past-12-months at 12 months post-baseline

    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic

Secondary outcomes

  1. Any Risky Riding or Driving at 3 Months - New England, USA

    Time frame: Past-90-days at 3 months post-baseline

    Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - New England

  2. Any Risky Riding or Driving at 12 Months - New England, USA

    Time frame: Past-90-days at 12 months post-baseline

    Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - New England

  3. Any Risky Riding or Driving at 3 Months - Prague, CZR

    Time frame: Past-90-days at 3 months post-baseline

    Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - Prague, Czech Republic

  4. Any Risky Riding or Driving at 12 Months - Prague, CZR

    Time frame: Past-90-days at 12 months post-baseline

    Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - Prague, Czech Republic

Sponsors and collaborators

Lead sponsor

Boston Children's Hospital

Other

Collaborators

  • Cambridge Health Alliance
  • Concord Hospital
  • Fallon Clinic
  • Tufts Medical Center
  • University of Vermont

Registry information

Important dates

Study start
2005
Primary completion
2008
Study completion
2010
First posted
Sep 28, 2005
Registry last updated
Aug 14, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.